scispace - formally typeset
M

M. G. Schwendinger

Researcher at Goethe University Frankfurt

Publications -  5
Citations -  871

M. G. Schwendinger is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Heteronuclear molecule & Pulse sequence. The author has an hindex of 4, co-authored 4 publications receiving 804 citations.

Papers
More filters
Journal ArticleDOI

A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients.

TL;DR: General pulse sequence elements that achieve sensitivity-enhanced coherence transfer from a heteronucleus to protons of arbitrary multiplicity are introduced and incorporated into heteronuclear correlation experiments, in conjunction with coherence selection by the formation of aheteronuclear gradient echo.
Journal ArticleDOI

Novel strategies for sensitivity enhancement in heteronuclear multi—dimensional NMR experiments employing pulsed field gradients

TL;DR: It is shown that in 3D sequences employing several Coherence Order Selective Coherence Transfer (COS-CT) steps, enhancement factors of up to 2 can be achieved, compatible with the use of heteronuclear gradient echoes, yielding spectra with excellent water suppression.
Journal ArticleDOI

PLUSH TACSY: Homonuclear planar TACSY with two-band selective shaped pulses applied to C(α),C' transfer and C (β),C (aromatic) correlations.

TL;DR: A new homonuclear Hartmann-Hahn-type mixing scheme is introduced that effects coherence transfer between resonances in two separated frequency bands and is applied to Cα,C′ transfer and to the transfer between Cβ and aromatic carbon spins.
Journal ArticleDOI

Abstract 3284: HB-201 and HB-202, an arenavirus-based immunotherapy, induces tumor T cell infiltration in patients with HNSCC and other HPV16+ tumors

TL;DR: HB-201 and HB-202, an werenavirus-based immunotherapy, induces tumor T cell infiltration in patients with HNSCC and other HPV16+ tumors and the ability of replicating arenavirus vectors to incorporate a broad range of antigens and the potent T cell inducing capacity provide a strong rationale to apply this novel therapy to other cancers.